Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome : A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group

van de Loosdrecht, Arjan A. ; Kern, Wolfgang ; Porwit, Anna LU ; Valent, Peter ; Kordasti, Sharham ; Cremers, Eline ; Alhan, Canan ; Duetz, Carolien ; Dunlop, Alan and Hobo, Willemijn , et al. (2023) In Cytometry Part B - Clinical Cytometry 104(1). p.77-86
Abstract

This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow-up of MDS patients.

Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
consensus, ELN, flow cytometry, myelodysplastic syndromes, standardization
in
Cytometry Part B - Clinical Cytometry
volume
104
issue
1
pages
10 pages
publisher
John Wiley & Sons Inc.
external identifiers
  • scopus:85112380647
  • pmid:34897979
ISSN
1552-4949
DOI
10.1002/cyto.b.22044
language
English
LU publication?
yes
additional info
Funding Information: Peter Valent was supported by the Austrian Science Fund (FWF) project F4704. Arjan A. van de Loosdrecht, Carolien Duetz, Nicolas Chapuis, and Michaela Fontenay are supported in part by research funding from MDS-RIGHT, which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 634789—“Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time”. Funding Information: Peter Valent was supported by the Austrian Science Fund (FWF) project F4704. Arjan A. van de Loosdrecht, Carolien Duetz, Nicolas Chapuis, and Michaela Fontenay are supported in part by research funding from MDS‐RIGHT, which has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 634789—“Providing the right care to the right patient with MyeloDysplastic Syndrome at the right time”. Funding Information: Horizon 2020; European Union; Austrian Science Fund, Grant/Award Number: F4704 Funding information Publisher Copyright: © 2021 The Authors. Cytometry Part B: Clinical Cytometry published by Wiley Periodicals LLC on behalf of International Clinical Cytometry Society.
id
7ccb7631-bb6a-4d92-91f1-85a098b89d51
date added to LUP
2024-01-11 13:32:17
date last changed
2024-12-07 09:33:17
@article{7ccb7631-bb6a-4d92-91f1-85a098b89d51,
  abstract     = {{<p>This article discusses the rationale for inclusion of flow cytometry (FCM) in the diagnostic investigation and evaluation of cytopenias of uncertain origin and suspected myelodysplastic syndromes (MDS) by the European LeukemiaNet international MDS Flow Working Group (ELN iMDS Flow WG). The WHO 2016 classification recognizes that FCM contributes to the diagnosis of MDS and may be useful for prognostication, prediction, and evaluation of response to therapy and follow-up of MDS patients.</p>}},
  author       = {{van de Loosdrecht, Arjan A. and Kern, Wolfgang and Porwit, Anna and Valent, Peter and Kordasti, Sharham and Cremers, Eline and Alhan, Canan and Duetz, Carolien and Dunlop, Alan and Hobo, Willemijn and Preijers, Frank and Wagner-Ballon, Orianne and Chapuis, Nicolas and Fontenay, Michaela and Bettelheim, Peter and Eidenschink-Brodersen, Lisa and Font, Patricia and Johansson, Ulrika and Loken, Michael R. and te Marvelde, Jeroen G. and Matarraz, Sergio and Ogata, Kiyoyuki and Oelschlaegel, Uta and Orfao, Alberto and Psarra, Katherina and Subirá, Dolores and Wells, Denise A. and Béné, Marie C. and Della Porta, Matteo G. and Burbury, Kate and Bellos, Frauke and van der Velden, Vincent H.J. and Westers, Theresia M. and Saft, Leonie and Ireland, Robin}},
  issn         = {{1552-4949}},
  keywords     = {{consensus; ELN; flow cytometry; myelodysplastic syndromes; standardization}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{77--86}},
  publisher    = {{John Wiley & Sons Inc.}},
  series       = {{Cytometry Part B - Clinical Cytometry}},
  title        = {{Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome : A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group}},
  url          = {{http://dx.doi.org/10.1002/cyto.b.22044}},
  doi          = {{10.1002/cyto.b.22044}},
  volume       = {{104}},
  year         = {{2023}},
}